| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 463,349 | 444,988 | 429,057 | 347,732 | | Cost of Revenue | 162,797 | 156,093 | 150,939 | 99,714 | | | Gross Profit | 300,552 | 288,895 | 278,118 | 248,018 | | | Operating Expenses | | Research Development | 22,640 | 21,202 | 27,256 | 627,148 | | Selling General and Administrative | 129,009 | 123,575 | 142,323 | 104,911 | | Non Recurring | 8,386 | 1,475 | 48,050 | 8,376 | | Others | 53,349 | 52,862 | 53,349 | 29,515 | | | | Total Operating Expenses | 213,384 | 199,114 | 270,978 | 769,950 | | | | Operating Income or Loss | 87,168 | 89,781 | 7,140 | (521,932) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,074 | 5,094 | (814) | (3,265) | | Earnings Before Interest And Taxes | 90,242 | 94,875 | 6,326 | (525,197) | | Interest Expense | 22,218 | 27,592 | 23,103 | 2,473 | | Income Before Tax | 68,024 | 67,283 | (16,777) | (527,670) | | Income Tax Expense | 25,536 | 29,348 | (6,055) | 20,797 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,488 | 37,935 | (10,722) | (548,467) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,488 | 37,935 | (10,722) | (548,467) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,488 | $37,935 | ($10,722) | ($548,467) |
|
0.31% Nasdaq 
0.05%
Income Statement
